KYNTRA BIO, INC. (KYNB)
Pharmaceutical Preparations · Healthcare · $3.7B
Intrinsic Value (Consensus)
$673.94
Current Price
$907.40
Margin of Safety
-25.7%
25.7% Above Intrinsic Value
Value: $674
Price: $907
Valuation Model Estimates
Current Price: $907.40
DCF (Discounted Cash Flow)
Not applicable
—
Graham Number
Not applicable
—
Earnings Power Value
$440.49
Relative Value (P/E)
$907.40
Dividend Discount Model
Not applicable
—
Consensus Value
$673.94
Model Assumptions
Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Key Financials
- EPS (TTM)
- $45.37
- EPS (Forward)
- $47.64
- Book Value
- $-7.42
- P/E Ratio
- 20.0
- Forward P/E
- 19.0
- PEG Ratio
- —
- ROE
- N/A
- Debt/Equity
- —
- Revenue Growth
- -78.3%
- Earnings Growth
- 5.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Data last updated: 2026-06-12
Source: Yahoo Finance